Want to join the conversation?
$BMY's 1Q16 revenue grew 9% versus 1Q15 due to higher Opdivo, Eliquis and Daklinza product sales. US and Europe revenue rose in the quarter, mainly due to higher demand for Opdivo and Eliquis. Decrease in Rest of the World revenue was driven by lower demand due to increased competition for the Hepatitis C Franchise in Japan.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.